Definitive Contract W81XWH20C0107

Award Date 9/21/20
Potential Completion Date 3/31/25
Potential Value $2.2M
Funding Federal Agency
Medical Command
Contracting Federal Agency
Defense Health Agency
Awardee
Ifyber LLC
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ithaca, NY, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
27
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $1,986,378 Definitive Contract to Synedgen, Inc., a small business prime contractor, to conduct Phase II Small Business Innovation Research (SBIR) efforts for the development of technologies to control scar formation after burn injuries. The contract is designated as a Total Small Business set-aside and has an ultimate completion date of April 1, 2023. Synedgen, a for-profit manufacturer with expertise in regenerative medicine...
The Department of the Army Medical Command awarded a $549,725 firm fixed price Small Business Innovation Research Program Phase III follow-on medical research and development contract to Synedgen, Inc. for the development of technologies that control scar formation after burn injuries. As the prime contractor, Synedgen will leverage its expertise in regenerative medicine and wound healing to advance scientific knowledge and technologies aimed at reducing scarring and improving outcomes for...
This is a $3,111,212 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Kericure Inc., a woman-owned small business, for the clinical validation of a portable, ruggedized antimicrobial wound dressing for the management of large surface area burns in prolonged field care and long-term care settings. The contract is part of the Small Business Innovation Research (SBIR) Program's Phase III, which focuses on the demonstration and delivery of technologies that have...
The U.S. Air Force Research Laboratory (AFRL) awarded a $1,245,650.00 SBIR Phase II contract to Nanoguard Medical Solutions, LLC, a small disadvantaged business, for the development of a "SAVING LIVES IN COMBAT - A REVOLUTIONARY NANOFIBER WOUND CARE" product. The contract is a firm fixed-price purchase order with a period of performance through February 17, 2026. This SBIR Phase II action is part of the AFRL's efforts to support the development of innovative technologies for defense...
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Antimicrobial Materials Inc., a for-profit, manufacturing organization structured as a Subchapter S corporation. The contract has a firm fixed price of $149,497.51 and was awarded on July 19, 2017 with a completion date of November 23, 2018. The contract is set aside for small businesses and is focused on research and...
The U.S. Army Medical Command awarded a $1,155,968.00 Firm Fixed Price Definitive Contract to Altrazeal Life Sciences Inc. (doing business as Uluru), a small business manufacturer of medical equipment. The contract is for a 24-month Phase II Small Business Innovation Research (SBIR) project titled "Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire." The research and development work will be performed in Addison, Texas and is expected to be...
<p>This is a $1,432,104.50 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Medical Command (MEDCOM) to Silk Technologies, Ltd., a for-profit manufacturer located in Maple Grove, Minnesota. The contract was awarded on June 29, 2016 and has a final completion date of June 12, 2019. It is a fixed-price level of effort contract. The contract is designated as a total small business set-aside. No major subcontractors are mentioned.</p>
This $167,470.02 Phase I Small Business Innovation Research (SBIR) contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Kericure Inc., a small disadvantaged, woman-owned biotechnology company specializing in novel wound care products. The contract is for research and development efforts on a ruggedized, spray-on antimicrobial wound dressing for treatment of multiple sulfur mustard-induced dermal injuries in theater to mitigate...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command (MEDCOM) to Memsel Inc., a self-certified small disadvantaged business. The $249,918.26 contract is for the development of a multi-component hydrogel containing stabilized, encapsulated bacteriophages for the treatment of drug-resistant bacterial infections. This SBIR Phase I contract was set aside for small businesses and is part of MEDCOM's broader efforts to identify...

The U.S. Department of the Army Medical Command has awarded a $2,195,569.75 definitive contract to Ifyber LLC, a small business located in Ithaca, New York. The contract is for the research and development of "Standard-Issue Antimicrobial Combat Burn Gauze" under Phase II of the Small Business Innovation Research (SBIR) program. The award has a total small business set-aside designation and will support work over a four-year period through March 2025. In addition to this contract, Ifyber has also received two federal grants totaling over $3.5 million from the Defense Health Agency and the National Institutes of Health to support its research in antimicrobial and anti-biofilm technologies for wound care applications.

Generated 4/8/25, 10:00 AM